Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit at CBD Expo East in Orlando, Florida

SAN DIEGO, Dec. 6, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health will be exhibiting its line of eco-friendly cannabidiol (CBD) hemp oil products for pets at CBD Expo East in Orlando, Fla., on Dec. 7-8.

“It is an honor to be able to educate people on the benefits of CBD for animals on this national stage and express how passionate I am to lead a company whose overall goal is to reduce waste by creating eco-friendly products and production methods,” said Phyto Animal Health CEO Ian Quinn. “I look forward to presenting alongside my canine partner Dante.”

CBD Expo East, one of the largest CBD event platforms in the United States, allows businesses and consumers to interact and share expert knowledge on the benefits of CBD and discuss the abundance of market opportunities. The event will feature an estimated attendance of more than 4,500 attendees, 90 exhibitors and many expert speakers.

During the event, Phyto Animal Health CEO Ian Quinn will host a presentation on the benefits of CBD for pets and the growing acceptance among veterinarians. His presentation will take place on Dec. 7 at 4:00 p.m.  In addition, attendees will have the chance to meet the inspiration behind the brand, Dante the Pit Bull.

Phyto Animal Health offers a line of CBD hemp oil supplements including tinctures, treats and concentrates for cats, dogs and horses. CBD hemp oil has been researched by top veterinarians for cardiovascular, pain management, orthopedic, and mental health in animals.

“This conference is a great opportunity for Phyto Animal Health to showcase its many accomplishments and inform people why this segment of the CBD market is looking to change the future of veterinary medicine,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope our participation in CBD Expo East will allow us valuable networking opportunities, as the national CBD market is poised to increase to more than $22 billion by 2022.”

To learn more, visit the Phyto Animal Health at Booth #202 or at

About Phyto Animal Health

As a company that cares about the health and wellbeing of all animals, Phyto Animal Health also cares about the earth. Using the least amount of water and other resources to create its products, the Company aims to leave the smallest footprint possible while helping provide cats, dogs and horses with the nutritional support they need to have outstanding mental and physical health.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]